Flossbach Von Storch’s Idexx Laboratories IDXX Stock Holding History

Flossbach Von Storch’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1M	Sell	18,034 -36,097	-67%	-$23.1M	0.05%	73
2025 Q4	$36.6M	Sell	54,131 -56,403	-51%	-$38.4M	0.15%	59
2025 Q3	$70.6M	Sell	110,534 -130,591	-54%	-$79.3M	0.28%	48
2025 Q2	$129M	Sell	241,125 -310,639	-56%	-$149M	0.53%	33
2025 Q1	$232M	Buy	551,764 +78,428	+17%	+$34.1M	1%	28
2024 Q4	$196M	Buy	473,336 +464,791	+5,439%	+$204M	0.78%	31
2024 Q3	$4.32M	Buy	8,545 +5,215	+157%	+$2.53M	0.02%	87
2024 Q2	$1.62M	Buy	3,330 +281	+9%	+$141K	0.01%	108
2024 Q1	$1.65M	Hold	3,049	–	–	0.01%	106
2023 Q4	$1.69M	Buy	+3,049	New	+$1.43M	0.01%	106

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Flossbach Von Storch's IDXX Position: Q1 2026 in Review

Flossbach Von Storch reduced its Idexx Laboratories (IDXX) stake by 67% in Q1 2026, selling an estimated $23.1M and leaving 18,034 shares worth $10.1M. The position accounts for 0.05% of the portfolio, ranked #73.

Flossbach Von Storch first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $232M in Q1 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Flossbach Von Storch held 18,034 shares of Idexx Laboratories worth $10.1M as of Q1 2026.
Flossbach Von Storch sold 36,097 Idexx Laboratories shares in Q1 2026, an estimated $23.1M.
Idexx Laboratories made up 0.05% of Flossbach Von Storch's portfolio in Q1 2026, its #73 holding.
Flossbach Von Storch first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
Flossbach Von Storch's Idexx Laboratories position peaked at $232M in Q1 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Flossbach Von Storch's 13F filing for Q1 2026, filed 29 Apr 2026.